Literature DB >> 24482121

Progestational agents for treating threatened or established preterm labour.

Lin-Lin Su1, Miny Samuel, Yap-Seng Chong.   

Abstract

BACKGROUND: Prematurity is not only the leading cause of perinatal morbidity and mortality but is associated with long-term impairment. Studies of various tocolytic agents have shown mixed results with little effect in improving pregnancy duration and insufficient data to confirm a definite beneficial effect on neonatal morbidity or mortality. Progesterone is known to have an inhibitory effect on uterine contractility and is thought to play a key role in the maintenance of pregnancy until term.
OBJECTIVES: To determine if the use of progestational agents is effective as a form of treatment or co-treatment for women with threatened or established preterm labour with intact membranes. SEARCH
METHODS: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 August 2013), CENTRAL (The Cochrane Library 2013, Issue 10), MEDLINE (1966 to August 31 2013) and Embase (1974 to 31 August 2013). We checked the reference lists of all included studies to identify any additional studies and communicated with authors and the pharmaceutical industry. SELECTION CRITERIA: Randomised controlled trials that compared progestational agents, given either alone or in combination with other tocolytics, with a control group receiving another tocolytic, placebo or no treatment, for the treatment of preterm labour. DATA COLLECTION AND ANALYSIS: Two review authors independently extracted data and assessed trial quality. MAIN
RESULTS: Eight studies were included in this review, involving 563 women, but only seven studies, involving 538 women, contributed data for analyses. There are some data suggesting that the use of progestational agents results in a reduction of preterm deliveries at less than 37 weeks of gestation and an increase in birthweight. The use of a progestational agent may also reduce the frequency of uterine contractions, prolong pregnancy and attenuate the shortening of cervical length. However, the analysis was limited by the relatively small number of available studies. The power of the meta-analysis was also limited by the varying types, dosages and routes of administration of progesterone. AUTHORS'
CONCLUSIONS: There is insufficient evidence to advocate progestational agents as a tocolytic for women presenting with preterm labour.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24482121     DOI: 10.1002/14651858.CD006770.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  9 in total

Review 1.  Tocolytics for delaying preterm birth: a network meta-analysis (0924).

Authors:  Amie Wilson; Victoria A Hodgetts-Morton; Ella J Marson; Alexandra D Markland; Eva Larkai; Argyro Papadopoulou; Arri Coomarasamy; Aurelio Tobias; Doris Chou; Olufemi T Oladapo; Malcolm J Price; Katie Morris; Ioannis D Gallos
Journal:  Cochrane Database Syst Rev       Date:  2022-08-10

2.  Cost-effectiveness of antenatal corticosteroids and tocolytic agents in the management of preterm birth: A systematic review.

Authors:  Elizabeth Sebastian; Chloe Bykersma; Alexander Eggleston; Katherine E Eddy; Sher Ting Chim; Rana Islamiah Zahroh; Nick Scott; Doris Chou; Olufemi T Oladapo; Joshua P Vogel
Journal:  EClinicalMedicine       Date:  2022-06-03

3.  Progesterone Gel and Placebo Prolonged Pregnancy More Effectively Than Intravenous Tocolysis Alone in Women with Preterm Labor.

Authors:  Ylva Vladic Stjernholm; Tomislav Vladic; Giovanna Marchini
Journal:  Gels       Date:  2022-04-26

4.  Pessary or Progesterone to Prevent Preterm delivery in women with short cervical length: the Quadruple P randomised controlled trial.

Authors:  Maud D van Zijl; Bouchra Koullali; Christiana A Naaktgeboren; Ewoud Schuit; Dick J Bekedam; Etelka Moll; Martijn A Oudijk; Wilhelmina M van Baal; Marjon A de Boer; Henricus Visser; Joris van Drongelen; Flip W van de Made; Karlijn C Vollebregt; Moira A Muller; Mireille N Bekker; Jozien T J Brons; Marieke Sueters; Josje Langenveld; Maureen T Franssen; Nico W Schuitemaker; Erik van Beek; Hubertina C J Scheepers; Karin de Boer; Eveline M Tepe; Anjoke J M Huisjes; Angelo B Hooker; Evelyn C J Verheijen; Dimitri N Papatsonis; Ben Willem J Mol; Brenda M Kazemier; Eva Pajkrt
Journal:  BMC Pregnancy Childbirth       Date:  2017-09-04       Impact factor: 3.007

5.  In silico analysis of the Mus musculus uterine gene expression landscape during pregnancy identifies putative upstream regulators for labour.

Authors:  Febilla Fernando; Souad Boussata; Aldo Jongejan; Joris A van der Post; Gijs Afink; Carrie Ris-Stalpers
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

6.  Progesterone - Effective for Tocolysis and Maintenance Treatment After Arrested Preterm Labour?: Critical Analysis of the Evidence.

Authors:  Werner Rath; Ruben-J Kuon
Journal:  Geburtshilfe Frauenheilkd       Date:  2019-05-13       Impact factor: 2.915

Review 7.  Ethanol for preventing preterm birth in threatened preterm labor.

Authors:  David M Haas; Amanda M Morgan; Samantha J Deans; Frank P Schubert
Journal:  Cochrane Database Syst Rev       Date:  2015-11-05

8.  Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trial.

Authors:  Kaitlin Siou; Sharon L Walmsley; Kellie E Murphy; Janet Raboud; Mona Loutfy; Mark H Yudin; Michael Silverman; Noor N Ladhani; Lena Serghides
Journal:  Pilot Feasibility Stud       Date:  2016-08-12

9.  The use of progesterone during pregnancy to prevent preterm birth.

Authors:  Eman S Alsulmi; Malikah Alfaraj; Yaser Faden; Noura Al Qahtani
Journal:  Saudi Med J       Date:  2020-04       Impact factor: 1.484

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.